All the studies involving 406 T2DM patients showed that YQP plus conventional treatment might significantly reduce CRP (WMD = −0.58; 95% CI [−0.88,−0.28]; p=0.0002, random effects model; see Figure 9). This evidence concerns the gene CRP and type 2 diabetes mellitus.